Long-Term Data Show Baricitinib Is Safe & Effective for RA
Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
Rituximab Receives Label Update for ANCA-Associated Vasculitis
FDA Approves Subcutaneous Tocilizumab for Ages 2–17
Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence
Revised Application Expected for IV Meloxicam; Plus EU Approves Tildrakizumab
More Evidence TNF Inhibitors Raise Risk of Peripheral Neuropathy
TNFi Exposure in Utero
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 17
- Next Page »